Implementation of Serological and Molecular Tools to Inform COVID-19 Patient Management

Explore a comprehensive 53-minute keynote presentation delivered by Dr. Jennifer Taher, focusing on the implementation of serological and molecular tools for COVID-19 patient management. Gain insights into the GENCOV study, which links laboratory data with patient characteristics to understand factors contributing to variability in COVID-19 outcomes. Learn about the study protocol, clinical characteristics increasing hospitalization odds, and survey results related to participants' understanding of COVID-19 serological testing. Discover the collaborative efforts of 25 co-investigators across 6 Ontario hospital sites, studying 1,500 COVID-19 patients over a 12-month period. Engage in a live Q&A session following the presentation to deepen your understanding of this crucial research.